Employment Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Board of Director's Operating Report for Financial Statement At
Board of Director’s Operating Report for Financial Statement at December 31, 2008 126 Financial Statement 2008 - Management Report Shareholders, The 2008 financial statements, prepared on the basis of IAS/IFRS international accounting standards, report on your company’s twenty-eighth year in business, closing with a profit of 21.2 million euro (+ 18.7% over 2007), after payment of 7.8 million Euro in taxes. R.O.E. was 27.40%, significantly higher than in 2007 (24.05%). On the topic of competitive positioning, note that in 2008 the company ranked fifth in its sector in terms of outstanding credit, with a market share of 6.0%, and fourth in terms of advances and payments made, with a market share of 6.7% (source: Assifact). The annual profit, though it did reflect the effects of certain non-recurrent events, is definitely noteworthy in terms of management of regular operations. In the year 2008 profit margins reflected replacement of about 3.0 million Euro in gains from purchases of credit not at face value (now a residual activity), which were entered under “Other operating income” in 2007, with profit margins from characteristic operations, marking the completion of the commercial strategy undertaken since 2006 aiming to improve performance on the working capital market for customer companies, the number of which has definitely grown (+ 43% active transferring customers). The Operating Margin was 49.2 million euro, up 12.4% over 2007. This performance is primarily attributable to Interest Margin dynamics, which have settled at 34.0 million euro (+26.4% over 2007), while Net Commissions were worth 15.2 million euro (-10.0 % since 2007). -
Global Equity Capital Markets Review
Global Equity Capital Markets Review FIRST QUARTER 2020 | MANAGING UNDERWRITERS Global Equity Capital Markets Review First Quarter 2020 | Managing Underwriters Global Deals Intelligence Global Initial Public Offerings GLOBAL ECM ACTIVITY HITS FOUR-YEAR LOW, AMIDST RECORD VOLATILITY $50 400 Equity capital markets activity totaled US$126.6 billion during the first quarter of 2020, a 2% decline $45 compared to a year ago and the slowest annual period for global equity capital markets activity since 350 Thousands 2016. By number of issues, 927 ECM offerings were brought to market during the year, a 2% decrease compared to a year ago and a four-year low. Amidst record market volatility, March 2020 ECM volume $40 decreased 60% compared to February of this year, marking the slowest month for global equity capital 300 markets proceeds since October 2011. $35 250 MARCH IPO PROCEEDS DOWN 37%; FIRST QUARTER GLOBAL IPOs UP 75% $30 Global initial public offering activity during the first quarter of 2020 totaled US$25.8 billion, a 75% increase compared to last year and the strongest opening period for global IPOs since 2018. IPOs on $25 200 US exchanges increased 39% during the first quarter of 2020, while China-domiciled IPOs totaled $20 US$11.0 billion during the first quarter of 2020, a 92% increase and a nine-year high. During the March 150 2020, global IPO activity totaled US$6.9 billion, a 37% decline compared to February 2020 and the slowest month for new listings since August 2019. $15 100 $10 CONVERTIBLE OFFERINGS DECLINE 35%, FALLING TO FOUR-YEAR LOW Global convertible offerings totaled US$25.4 billion during the first quarter of 2020, accounting for 20% of 50 $5 global equity capital markets activity, compared to 30% during the first quarter of 2019. -
Espinal, Et Al. V. Didi Global Inc., Et Al. 21-CV-05807-U.S. District Court
Espinal v. Didi Global Inc. et al, Docket No. 1:21-cv-05807 (S.D.N.Y. Jul 06, 2021), Court Docket Current on Bloomberg Law as of 2021-07-08 13:03:33 U.S. District Court Southern District of New York (Foley Square) CIVIL DOCKET FOR CASE #: 1:21-cv-05807-LAK Espinal v. Didi Global Inc. et al Date Filed: Jul 6, 2021 Nature of suit: 850 Securities/ Commodities Assigned to: Judge Lewis A. Kaplan Cause: 15:77 Securities Fraud Jurisdiction: Federal Question Jury demand: Plaintiff Parties and Attorneys Plaintiff Rafaela Espinal individually and on behalf of all others similarly situated Representation Gregory Bradley Linkh Glancy Prongay & Murray LLP 230 Park Avenue Suite 358 New York, NY 10169 (212) 682-5340 [email protected] ATTORNEY TO BE NOTICED Defendant Didi Global Inc. formerly known as: Xiaoju Kuaizhi Inc. Defendant Will Wei Cheng © 2021 The Bureau of National Affairs, Inc. All Rights Reserved. Terms of Service // PAGE 1 Espinal v. Didi Global Inc. et al, Docket No. 1:21-cv-05807 (S.D.N.Y. Jul 06, 2021), Court Docket Defendant Alan Yue Zhuo Defendant Jean Qing Liu Defendant Stephen Jingshi Zhu Defendant Zhiyi Chen Defendant Martin Chi Ping Lau Defendant Kentaro Matsui Defendant Adria Perica Defendant Daniel Yong Zhang Defendant Goldman Sachs (ASIA) L.L.C. Defendant Morgan Stanley & Co. LLC Defendant J.P. Morgan Securities LLC Defendant Bofa Securities, Inc. Defendant Barclays Capital Inc. Defendant China Renaissance Securities (Hong Kong) Limited Defendant China International Capital Corporation Hong Kong Securities Limited © 2021 The Bureau of National Affairs, Inc. -
PEI 300 Guess Who’S Back on Top?
Issue 165 | May 2018 | privateequityinternational.com PEI 300 Guess who’s back on top? THE ORACLE SPEAKS David Rubenstein on the future of private capital SECONDARIES ROUNDTABLE Keeping LPs front and centre WHY PRIVATE EQUITY? The asset allocation special PLUS: the PEI Q1 Fundraising Report; IRRs vs money multiples; introducing the CEPRES model portfolio; Texas TRS goes Canadian; inside the PE retail blowouts; and much more… Equistone announced the successful final We are one of close of Fund VI at its €2.8bn hard cap in March 2018. Europe’s most Equistone has made three investments for Fund VI and will continue to source deals active mid-market and build value with management teams across our target markets. investors. www.equistonepe.com Evercore acted as the exclusive global placement agent for Equistone Partners Europe Fund VI. © EQUISTONE PARTNERS EUROPE LIMITED Authorised and regulated by The Financial Conduct Authority. PE International Ad May 2018.indd 1 18/04/2018 15:18 Riding high historically it’s been successful, but it needs to ISOBEL ISSN 1474–8800 | ISSUE 165 | MARKHAM work hard to avoid becoming a victim of that MAY 2018 EDITOR'S success. The signs are already there that this LETTER is starting to happen. Senior Editor, Private Equity Toby Mitchenall Tel: +44 207 566 5447 Sandra Robertson, chief investment officer [email protected] and chief executive of the UK’s £3 billion ($4.3 Americas Editor, Private Equity Marine Cole billion; €3.4 billion) Oxford University Endow- Tel: +1 212 633 1455 [email protected] ment -
Including League Tables of Financial Advisors
An Acuris Company Finding the opportunities in mergers and acquisitions Global & Regional M&A Report 2019 Including League Tables of Financial Advisors mergermarket.com An Acuris Company Content Overview 03 Global 04 Global Private Equity 09 Europe 14 US 19 Latin America 24 Asia Pacific (excl. Japan) 29 Japan 34 Middle East & Africa 39 M&A and PE League Tables 44 Criteria & Contacts 81 mergermarket.com Mergermarket Global & Regional Global Overview 3 M&A Report 2019 Global Overview Regional M&A Comparison North America USD 1.69tn 1.5% vs. 2018 Inbound USD 295.8bn 24.4% Outbound USD 335.3bn -2.9% PMB USD 264.4bn 2.2x Latin America USD 85.9bn 12.5% vs. 2018 Inbound USD 56.9bn 61.5% Outbound USD 8.9bn 46.9% EMU USD 30.6bn 37.4% 23.1% Europe USD 770.5bn -21.9% vs. 2018 50.8% 2.3% Inbound USD 316.5bn -30.3% Outbound USD 272.1bn 28.3% PMB USD 163.6bn 8.9% MEA USD 141.2bn 102% vs. 2018 Inbound USD 49.2bn 29% Outbound USD 22.3bn -15.3% Ind. & Chem. USD 72.5bn 5.2x 4.2% 17% 2.6% APAC (ex. Japan) USD 565.3bn -22.5% vs. 2018 Inbound USD 105.7bn -14.8% Outbound USD 98.9bn -24.5% Ind. & Chem. USD 111.9bn -5.3% Japan USD 75.4bn 59.5% vs. 2018 Inbound USD 12.4bn 88.7% Global M&A USD 3.33tn -6.9% vs. 2018 Outbound USD 98.8bn -43.6% Technology USD 21.5bn 2.8x Cross-border USD 1.27tn -6.2% vs. -
Preliminary Offering Circular
IMPORTANT NOTICE NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY INTO THE UNITED STATES IMPORTANT: You must read the following before continuing. The following applies to the attached preliminary offering circular (the ‘‘Offering Circular’’) following this page, and you are therefore advised to read this carefully before reading, accessing or making any other use of the Offering Circular. In accessing the Offering Circular, you agree to be bound by the following terms and conditions, including any modifications to them any time you receive any information from the Issuer or the Guarantor (each as defined in the Offering Circular) as a result of such access. NOTHING IN THIS ELECTRONIC TRANSMISSION CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. THE BONDS (THE ‘‘BONDS’’) AND THE GUARANTEE DESCRIBED HEREIN HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE ‘‘SECURITIES ACT’’), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR OTHER JURISDICTION AND THE BONDS AND THE GUARANTEE MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES, EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND APPLICABLE STATE OR LOCAL SECURITIES LAWS. THIS OFFERING IS MADE SOLELY IN OFFSHORE TRANSACTIONS PURSUANT TO REGULATION S UNDER THE SECURITIES ACT. THE FOLLOWING OFFERING CIRCULAR MAY NOT BE FORWARDED OR DISTRIBUTED TO ANY OTHER PERSON ELECTRONICALLY OR OTHERWISE, AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER, AND IN PARTICULAR, MAY NOT BE FORWARDED TO ANY UNITED STATES ADDRESS. -
Interim Report for the Six Months Ended 30 June 2008
China Everbright Limited 中國光大控股有限公司 (Stock Code: 165) Interim Report For the six months ended 30 June 2008 簡單成就價值 Making Wealth Simple BOARD OF DIRECTORS Tang Shuangning Chairman Zang Qiutao Deputy Chairman Chen Shuang Chief Executive Officer Tang Chi Chun, Richard Chief Financial Officer + Wang Weimin * Ng Ming Wah, Charles * Seto Gin Chung, John * Lin Zhijun + Non-executive Director * Independent Non-executive Directors COMPANY SECRETARY LEGAL ADVISOR Chan Ming Kin Messrs. Wilkinson & Grist REGISTERED OFFICE SHARE REGISTRARS Room 4001, 40th Floor Tricor Secretaries Limited Far East Finance Centre 26th Floor, Tesbury Centre 16 Harcourt Road 28 Queen’s Road East Hong Kong Wanchai Hong Kong PRINCIPAL BANKERS AUDITORS Standard Chartered Bank (Hong Kong) Limited KPMG Bank of Communications Company, Limited Fubon Bank (Hong Kong) Limited Hang Seng Bank Limited WEBSITE ADDRESS http://www.everbright165.com.hk STOCK CODE: 165 China Everbright Limited Interim Report 2008 1 INTERIM RESULTS The Directors of China Everbright Limited (the “Company”) are pleased to announce the unaudited results of the Company and its subsidiaries (the “Group”) for the six months ended 30 June 2008. The interim financial report is prepared on a basis consistent with the accounting policies and methods adopted in the 2007 audited accounts. The interim financial report is unaudited, but has been reviewed by KPMG, in accordance with Hong Kong Standard on Review Engagements 2410, “Review of interim financial information performed by the independent auditor of the entity” issued by the Hong Kong Institute of Certified Public Accountants, KPMG’s review report to the Board of Directors of the Company is included on page 23. -
Life Sciences and Healthcare
Life Sciences and Healthcare Beijing Guangzhou Hong Kong Shanghai Shenzhen 27/F, North Tower 17/F, International Finance 26/F, One Exchange Square 24/F, HKRI Centre Two, 17/F, Tower One, Kerry Plaza Beijing Kerry Centre Place, 8 Huaxia Road, 8 Connaught Place, Central HKRI Taikoo Hui 1 Zhong Xin Si Road 1 Guanghua Road Zhujiang New Town Hong Kong 288 Shi Men Yi Road Futian District Chaoyang District Guangzhou 510623, China Shanghai 200041, China Shenzhen 518048, China Beijing 100020, China Tel: +86 10 5769 5600 Tel: +86 20 3225 3888 Tel: +852 3976 8888 Tel: +86 21 2208 1166 Tel: +86 755 8159 3999 Fax:+86 10 5769 5788 Fax:+86 20 3225 3899 Fax:+852 2110 4285 Fax:+86 21 5298 5599 Fax:+86 755 8159 3900 www.fangdalaw.com Life Sciences and Healthcare Life Sciences and Healthcare 01 The Preeminent China-based International Law Firm Founded in 1993 and one of the most prestigious law firms Our service to clients is premised on the dual foundations in the region, Fangda Partners has over 700 lawyers. We of strong local law capabilities and a global business outlook. serve a wide variety of major clients – including large MNCs, Our lawyers are qualified in many jurisdictions, including global financial institutions, leading Chinese enterprises the People's Republic of China, Hong Kong SAR, England and fast-growing Hi-tech companies – on an extensive range and Wales, the United States, Singapore and Australia. of commercial matters through our network offices in Beijing, Guangzhou, Hong Kong, Shanghai and Shenzhen, Our understanding of the laws and processes in major offering PRC law and Hong Kong law. -
Everbright Investment Conference 2014 Held in Xiamen
Everbright Investment Conference 2014 held in Xiamen More than 350 investors and industry experts participate to discuss investment opportunities exhibited locally and abroad On 29-31 October 2014, China Everbright Limited (“Everbright”, stock code: 165.HK) held the Everbright Investment Conference 2014 in Xiamen to explore the current economic development trends in China as well as investment opportunities and challenges China faces in the asset management industry, attracting a total of more than 350 investors and industry experts to participate in it. “Venturing Beyond Your Horizon” was the theme for the Investment Conference. Industry experts congregated to discuss the in-depth development trend of China’s economy and the asset management industry as well as to provide a comprehensive analysis of where China is situated in the global asset management market and the challenges to overcome. They explored how China can advance in the international capital market as well as further grasp global investment opportunities and to discover how to attract overseas capital into the Chinese market to further spring the momentum of China’s economic development. The conference began with a welcome remarks and opening speech by Everbright’s Executive Director and CEO Mr. Chen Shuang, followed by a keynote speech by Deputy General Manager of China Everbright Group Limited and Deputy Chairman of the Board of Directors of China Everbright Limited Dr. Liu Jun, and The National Council for Social Security Fund’s Vice-Chairman, Mr. Wang Zhongmin, talking about financial crisis and risk management as well as the economic ecosystem of internet investment. Mr. Chen Shuang, together with Sequoia Capital China’s Founding Managing Partner, Mr. -
League Tables
GLOBAL EQUITY CAPITAL MARKET LEAGUE TABLES Q1 2016 Q1 2016 MANAGER RANKINGS GLOBAL EQUITY, EQUITY LINKED & RIGHTS CONTENTS Bloomberg’s global equity offerings database consists of nearly 87,000 deals (with approximately 43,000 IPOs and over 43,000 additional offerings), and coverage of more than 500 financial advisors 1. Global market review and 500 legal advisors. 2. US market review LEAG<GO> for a full range of league tables 3. Canada market review IPO<GO> for Bloomberg’s equity offerings product 4. Latin America market review 5. EMEA market review Due to the dynamic nature of the Professional Service product, league table rankings may vary between this release 6. Asia market review and data found on the Bloomberg Professional Service. 7. Table criteria DATA SUBMISSIONS AND QUERIES Contact Phone Email North America Elizabeth Entrup +1 646 324 4666 [email protected] Irina Arefyeva +1 646 324 4663 [email protected] EMEA Karan Aswani +44 20 3525 4331 [email protected] Asia Pacific Billy Sun +886 2 7719 1571 [email protected] © 2015 Bloomberg Finance L.P. All rights reserved. Global Equity, Equity Linked & Rights: Industry Breakdown Global Equity Review Technology 27% 11% Financials 18% Q1 2016 credited Global Equity, Equity Linked & Rights volume decreased 56.27% to USD 102.5 Bln while deal 5% 27% count decreased 42.90% to 627 offerings year-on-year. Global Equity IPO volume decreased 65.23% year-on- 6% Energy 16% year to USD 14.1 Bln while the deal count decreased 36.23% to 176. Global Equity Linked volume decreased Health Care 9% 41.99% year-on-year to USD 15.8 Bln over 61 deals. -
View Annual Report
STEALTH BIOTHERAPEUTICS CORP FORM 20-F (Annual and Transition Report (foreign private issuer)) Filed 04/04/19 for the Period Ending 12/31/18 Telephone 617-600-6888 CIK 0001696396 Symbol MITO SIC Code 2834 - Pharmaceutical Preparations Industry Biotechnology & Medical Research Sector Healthcare Fiscal Year 12/31 http://www.edgar-online.com © Copyright 2020, EDGAR Online, a division of Donnelley Financial Solutions. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, a division of Donnelley Financial Solutions, Terms of Use. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission file number: 001-38810 STEALTH BIOTHERAPEUTICS CORP (Exact name of Registrant as specified in its charter) N/A (Translation of Registrant’s name into English) Cayman Islands (Jurisdiction of incorporation) Stealth BioTherapeutics Corp c/o Intertrust Corporate Services (Cayman) Limited 190 Elgin Avenue, George Town Grand Cayman KY1-9005 Cayman Islands (address of principal -
Global Debt Capital Markets Review
Global Debt Capital Markets Review FIRST QUARTER 2021 | MANAGING UNDERWRITERS An LSEG Business Global Debt Capital Markets Review First Quarter 2021 | Managing Underwriters Global Deals Intelligence Global Debt Capital Markets - Issue Type Composition (US$bil) $3,500 GLOBAL DEBT CAPITAL MARKETS ACTIVITY FLAT WITH US$2.5 TRILLION ABS MBS Federal Credit Agency Agency, Supranational, Sovereign Overall global debt capital markets activity totaled US$2.5 trillion during the first quarter of 2021, flat High Yield Corporate Investment Grade Corporate compared to the first quarter of 2020 and the fifth consecutive quarter to surpass US$2.0 trillion in $3,000 issuance. The number of new offerings brought to market during the first quarter of 2021 totaled 6,143, a 4% decline compared the first quarter of 2020. DCM issuance during the first three months of 2021 has increased 25% compared to the fourth quarter of last year but declined 6%, by number of issues. $2,500 INVESTMENT GRADE CORPORATE DEBT ISSUANCE FALLS 5% Global Investment Grade corporate debt offerings totaled US$1.2 trillion during the first quarter of 2021, $2,000 a 5% decrease compared to 2020 levels and the third largest quarter for global high-grade corporate debt on record. The US dollar marketplace, which saw a record levels of issuance during 2020, totaled US$436.8 during the first quarter of 2021, a 13% decline compared to a year ago. $1,500 GLOBAL HIGH YIELD DEBT PUSHES PAST US$200 BILLION FOR QUARTERLY RECORD $1,000 Global High Yield debt activity during first quarter 2021 reached US$205.1 billion, an increase of 83% compared to first quarter 2020 levels and the strongest three-month period for global high yield issuance on record and the first quarter to surpass US$200 billion.